|
Revolution Medicines Inc (NASDAQ: RVMD) |
|
Revolution Medicines Inc
RVMD's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Revolution Medicines Inc 's sales fell
in III. Quarter 2024 from the same quarter a year ago.
Biotechnology & Pharmaceuticals industry recorded
growth of revenues by 13.29 %
Revolution Medicines Inc net loss increased from $-108 millions, to $-156 millions in III. Quarter 2024,
• More on RVMD's Growth
|
|
Revolution Medicines Inc realized a net loss in trailing twelve months.
Revolution Medicines Inc realized cash reduction of $ -0.94 per share in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 9291.1.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.63.
• More on RVMD's Valuation
|
|
|
|
|
Revolution Medicines Inc realized net loss in trailing twelve months.
Revolution Medicines Inc realized cash outflow of $ -0.94per share in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 9291.1.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.63.
Revolution Medicines Inc Price to Book Ratio is at 4.4 higher than Industry Avg. of -0, and higher than S&P 500 Avg. of 0.02
• More on RVMD's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com